Wyld's Boysenberry gummy is its first to include three cannabinoids – THC, CBD and CBN – as well as botanical terpenes.

Wyld first introduced its sour gummies in May 2022 with Sour Cherry Indica-enhanced and Sour Apple Sativa-enhanced varieties.

Building on consumer interest and adoption of the gummy category, manufacturers and brand owners are expanding beyond traditional offerings with products made with minor cannabinoids and rosin.

In his webinar, “Edible Evolution in Cannabis: In Review and What’s to Come,” BDSA’s Rick Maturo covers trending product attributes.

The Oregon-based company focuses its efforts around four core pillars of commitment: Combating the Failed War on Drugs, Environmental Sustainability, Health & Wellness, and Social & Racial Justice.

Blood Orange THC:CBC 1:1 sativa-enhanced gummies will be available in the U.S. and Canada this spring.

Market research firm BDSA reported edibles brought in nearly $2.75 billion, up about $105 million from 2021.

Joining the Wyld CBD lineup are Peach CBD+CBC gummies, Grapefruit CBD+CBG sparkling water, and Blueberry Pomegranate CBD+CBN sparkling water.

Wyld’s newest brand, Good Tide, builds on its mission with company firsts — solventless hash rosin and tropical flavors — and represents an important milestone on its journey of introducing compostable, recyclable and plastic-free packaging.

Wyld is expanding its product offerings into Illinois, joining eight state cannabis markets and Canada.